Analystreport

Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) had its "outperform" rating re-affirmed by analysts at Cowen Inc. They now have a $165.00 price target on the stock, down previously from $200.00.

Jazz Pharmaceuticals plc - Ordinary Shares  (JAZZ) 
Last jazz pharmaceuticals plc - ordinary shares earnings: 2/25 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: jazzpharma.com